back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
15,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
30,000 | |
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,730 | ||
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
15,000 | |
| Filed 2016-06-20 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-33,616.20
-9,390 vol $3.58 each |
0 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$29,137
+8,139 vol $3.58 each |
49,479 | |
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
9,390 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
41,340 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,730 |